Business Context and Reporting Period
Company: Ares Commercial Real Estate Corporation
Filing Type: Form 8-K (Current Report)
Date of Report: October 21, 2015
Event: Entry into a Material Definitive Agreement regarding a credit facility amendment.
Key Financial Metrics
This filing does not report revenue, profit, cash flow, or general liquidity metrics. It specifically addresses the terms of a financing facility:
- Facility Name: UBS Facility (Revolving Master Repurchase Facility)
- Facility Size: $140.0 million
- Counterparty: UBS Real Estate Securities Inc.
- Interest Rate Structure (LIBOR + Spread):
- 1.88% for assets funded for one year or less.
- 2.08% for assets funded for more than one year but less than two years.
- 2.28% for assets funded for greater than two years.
Material Changes Versus Prior Period
The filing details an amendment to the existing UBS Facility with the following material changes:
- Maturity Extension: The initial maturity date was extended to October 21, 2018. This date is subject to annual extensions at UBS's sole discretion.
- Asset Class Restriction: Commercial real estate mezzanine loans are no longer an approved eligible asset class for financing under this facility.
- Rate Adjustment: New pricing tiers were established for assets funded after the extension date, excluding amortization of commitment and exit fees.
Guidance, Outlook, and Risks
Management Commentary: The filing is a factual disclosure of the amendment terms and does not contain forward-looking guidance or management commentary on future performance.
Risks and Contingencies:
- Discretionary Extension Risk: The facility's maturity is subject to annual extensions solely at the discretion of UBS.
- Asset Eligibility Risk: The removal of commercial real estate mezzanine loans as an eligible asset class may impact the Company's ability to finance specific portfolio assets under this facility.
Important Facts for Investor Verification
- Verify the impact of excluding commercial real estate mezzanine loans on the Company's current and future financing strategy.
- Confirm the Company's ability to secure alternative financing for mezzanine assets previously funded under the UBS Facility.
- Review the full text of Amendment No. 2 (Exhibit 10.1) for specific covenants and conditions regarding the annual extension discretion held by UBS.
- Assess whether the new interest rate spreads (1.88% to 2.28% over LIBOR) represent a favorable or unfavorable change compared to prior terms.